Advertisement

Topics

Companies Related to "Tonix Pharmaceuticals Present Breakthrough Therapy Designated PTSD Program" [Most Relevant Company Matches] RSS

06:27 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Tonix Pharmaceuticals Present Breakthrough Therapy Designated PTSD Program" found in our extensive corporate database of over 50,000 company records.

Showing "Tonix Pharmaceuticals Present Breakthrough Therapy Designated PTSD Program" Companies 1–25 of 4,900+

Extremely Relevant

Tonix Pharmaceuticals Holding Corp.

TONIX Pharmaceuticals is developing new therapies for challenging disorders of the central nervous system. The Company targets conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. TONIX reformulates known pharmaceutical agents to design drugs with opt...


TONIX Pharmaceuticals, Inc.

TONIX Pharmaceuticals is developing new therapies for challenging disorders of the central nervous system (CNS). The Company targets conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. TONIX re-engineers known pharmaceutical agents to design drugs wi...

TONIX Pharmaceuticals

TONIX Pharmaceuticals is developing new treatments for challenging disorders of the central nervous system. The Company’s most advanced program targets fibromyalgia syndrome based on very low dosage cyclobenzaprine, an active pharmaceutical ingredient used in higher doses in approved therapeutics in the U.S. Based on this foundation, the Company is bu...


Relevant

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AA...

Rocket Pharmaceuticals, Ltd.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (A...

P2V

Founded in 2009 and headquartered in Arlington, VA, P2V (an all-volunteer organization) pairs veterans, active duty military, and emergency first responders, particularly those who suffer from the stress of their service like PTSD and TBI, with shelter animals as part of their healing. P2V's Match Program assists heroes in adopting companion animals. P2V's Connection Program allows heroes who ar...

Psimei Pharmaceuticals plc

Psimei Pharmaceuticals plc, founded in 2001, is a world leader in the development of Boron Cellular Radiotherapy (BCR) products. These are designed to significantly improve the clinical effectiveness of radiotherapy in the treatment of cancer. At present only 30% of cancer patients receiving radiotherapy are "cured". This equates to complete clinical responses for up to 5 years. Psimei is currentl...

OPTIFAST Program

The OPTIFAST Program utilizes a stimuli-narrowing dietary intervention in combination with behavioral therapy techniques, nutrition and exercise education along with medical supervision. Stimuli narrowing limits the variety and quantity of available foods and flavors to decrease appetite. Together, the main components of the OPTIFAST Program--stimuli narrowing and behavioral therapy-have helped mo...

Pet Partners

Pet Partners, established as Delta Society in 1977, is an international nonprofit organization dedicated to improving human health and enriching lives through positive connections with therapy, service and companion animals. The organization’s Therapy Animal Program trains and evaluates volunteer therapy animal teams, its Service Animal Program provides ...

Cefak KG - switchboard

Efficient and low-risk natural remedies present a reasonable alternative to chemical-synthetic pharmaceuticals. The therapeutic principle of natural remedies does not aim at the suppression of symptoms but intends to understand and to treat the human being in its entirety.Natural remedies of herbal and homeopathic origin support the self-healing will of the body and allow of a gentle long-term the...

Santhera Pharmaceuticals Holding Ltd

Santhera Pharmaceuticals is a Swiss biopharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of neuromuscular diseases. Santhera’s vision is to become the leading specialty pharmaceuticals company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indic...

Genetix Pharmaceuticals, Inc.

Genetix Pharmaceuticals, Inc. is an emerging leader in treatments for severe genetic disorders based on a breakthrough gene therapy platform that uses a patient’s own genes to treat his/her disorder. Taking stem cells from a patient’s own bone marrow, Genetix uses a proprietary lentiviral technology to modify the genes and deliver corrective stem ...

MN Pharmaceuticals

MN Pharmaceuticals Its founder Prof. Mustafa Nevzat Pisak played an important role in establishing contemporary pharmacy in Turkey, in changing the academic pharmacy program to one fashioned on Western methods, and in the development of Turkish Pharmaceutical Industry.His "Laboratory" is one of the first manufacturers of injectable ampoules in Turkey. With its 8 employees, the laboratory moved to ...

BTL Industries

BTL Industries Limited designs, manufactures and sells medical equipment for physical therapy, cardiology, and medical aesthetics. Headquartered in Prague, the Czech Republic, the Company is among the world’s five largest physical therapy manufacturers. For the past 18 years, BTL Industries supplies its products through distributors designated for ...

Maxinovel Pharmaceuticals, Inc.

Maxinovel Pharmaceuticals, Inc. is a biotech company focusing on the discovery and development of Immuno-oncology therapy and targeted therapy. It will use its orally active Immuno-oncology product platform to bring effective combo product of multi-components in a single oral pill to the patients worldwide. For more info: www.maxinovel.com

MindFrame, Inc.

MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes fo...

AlphaCore Pharma

AlphaCore Pharma is an Ann Arbor-based private company focused on the development of ACP-501 as a therapy for acute coronary syndromes, and other high-risk atherosclerosis conditions. ACP-501 is recombinant human lecithin: cholesterol acyltransferase (or rhLCAT), an enzyme required for cholesterol metabolism. Additionally, ACP-501 is being developed to tre...

The Emily Program

The Emily Program was founded in 1993 by Dirk Miller, PhD, LP, after his sister Emily recovered from an eating disorder. To date, The Emily Program has provided more than 4,500 clients with comprehensive treatment for eating disorders. Recognizing that one size does not fit all, The Emily Program develops a personalized care plan for its patients that inco...

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals is the leader in discovering and developing novel, oral anti-inflammatory drugs that activate Nrf2, the primary regulator of cellular antioxidant and detoxification enzymes. Activation of this important biological target protects against a broad range of diseases associated with inflammation and oxidative stress. Reata is developing b...

Military Pathways

Military Pathways gives service personnel and their families the opportunity to learn more about mental health and alcohol use through anonymous self-assessments offered online, via telephone, and through events held at installations. The program is designed to help individuals identify symptoms and access assistance before a problem becomes serious. The self-assessments address alcohol use, PTSD,...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

EMD Pharmaceuticals

We are EMD Pharmaceuticals, a company focused on developing products and services for people suffering from cancer and other serious medical conditions. Our commitment to the pharmaceutical industry goes beyond the development of breakthrough treatments; we believe we should play a larger role in supporting people with unmet medical needs and their healthcare providers.

Medical Discoveries Inc.

Medical Discoveries, Inc. develops cures for major diseases though its novel oxidative therapy program, in-licensing promising technologies, and establishing development/marketing alliances for programs that address some of today’s most serious illnesses. The Company was founded on MDI-P, a novel oxidative therapy which is a stable solution rich in highly reactive hydrogen, chlorine and oxygen...

Fusion Pharmaceuticals, Inc.

Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company located in Hamilton, Ontario, Canada focused on becoming the leader in the targeted alpha therapy field. Fusion will exploit its unique expertise in linking medical isotopes to targeting molecules to create highly effective therapeutics. In addition to its lead program, FPX-01 with a clin...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...


More From BioPortfolio on "Tonix Pharmaceuticals Present Breakthrough Therapy Designated PTSD Program"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks